Answers are grounded in this paper and cite their sources.
Qualitative study reveals symptoms and impacts of narcolepsy type 2, highlighting significant patient experiences.
Introduction Narcolepsy type 2 (NT2) is characterized by excessive daytime sleepiness (EDS) alongside other diagnostically relevant symptoms, including disrupted nighttime sleep, sleep paralysis, and hypnagogic/hypnopompic hallucinations. This qualitative study amplifies the voices of patients to identify the most bothersome and meaningful symptoms and impacts of NT2. Methods Participants were recruited through a third-party recruitment vendor, patient advocacy groups, and a patient conference. Twenty adults diagnosed with NT2 completed concept-elicitation interviews discussing their experience with NT2. Interviews included open-ended questions and probes on topics informed by a targeted literature review. Participants rated bothersomeness (0–10) for current symptoms and impacts and reported their 3 most bothersome symptoms. Concept frequencies and bothersomeness ratings were used to evaluate salience (ie, reported by ≥50% of participants and average bothersomeness rating ≥5) and develop a conceptual disease model. Results Participants identified 30 symptoms and 38 impacts of NT2; 17 symptoms and 13 impacts were deemed salient. The most frequently reported salient symptoms included chronic daytime sleepiness (100%; mean [SD] bothersomeness: 8.6 [1.6]), brain fog (95%; 8.3 [1.5]), memory problems (90%; 7.5 [1.6]), fatigue (90%; 8.2 [1.7]), excessive napping (85%; 6.3 [2.8]), unintentional daytime sleep episodes (85%; 8.5 [2.1]), difficulty concentrating (80%; 8.2 [1.5]), and sleep inertia (80%; 7.8 [1.8]). Chronic daytime sleepiness, fatigue, and brain fog were most frequently mentioned among the 3 most bothersome symptoms. Salient impacts included difficulties with instrumental activities of daily living (100%; mean [SD] bothersomeness: 6.7 [2.7]), work (90%; 8.2 [2.1]), planning social activities (85%; 6.7 [1.9]), recreational activities (65%; 6.4 [1.9]), and school (50%; 9.0 [1.7]), as well as stress (70%; 6.2 [1.7]) and negative impacts on relationships (80%; 6.5 [2.4]) and mobility (50%; 6.5 [1.5]). Conclusion The lived experience of NT2 is defined not only by EDS but also by fatigue, sleep inertia, and cognitive difficulties. Further, NT2 has a substantial impact on daily functioning and quality of life. A conceptual disease model was developed to offer a structured representation of the lived experiences of patients with NT2, providing a critical framework for understanding patient perspectives and guiding future research and interventions. Support (if any)
No takes yet. Share an insight, caveat, or question.
Casstevens et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: